Approval · Notice of Compliance 12868 · 2011
EPREX STERILE SOLUTION: Notice of Compliance 12868
Issued December 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12868
- Date
- December 14, 2011
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the Drug Substance Manufacturing Process
- Therapeutic class
- Erythropoiesis Regulating Hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EPREX STERILE SOLUTION | Not yet assigned | — |
Medicinal ingredients
- EPOETIN ALFA 1,000 UNIT per 0.5ML
- EPOETIN ALFA 2,000 UNIT per 0.5ML
- EPOETIN ALFA 3,000 UNIT per 0.3ML
- EPOETIN ALFA 4,000 UNIT per 0.4ML
- EPOETIN ALFA 5,000 UNIT per 0.5ML
- EPOETIN ALFA 6,000 UNIT per 0.6ML
- EPOETIN ALFA 7,000 UNIT per 0.7ML
- EPOETIN ALFA 8,000 UNIT per 0.8ML
- EPOETIN ALFA 9,000 UNIT per 0.9ML
- EPOETIN ALFA 10,000 UNIT per 1ML
- EPOETIN ALFA 20,000 UNIT per 0.5ML
- EPOETIN ALFA 30,000 UNIT per 0.75ML
- EPOETIN ALFA 40,000 UNIT per 1ML
- EPOETIN ALFA 2,000 UNIT per 1ML
- EPOETIN ALFA 4,000 UNIT per 1ML